Helping our Clients Turn Hope into Reality
Andelyn Biosciences is a World Leader in Cell and Gene Therapy Contract Development and Manufacturing, supporting clients through all phases of development and commercialization. We help innovate and produce new gene therapies in order to transform, extend and save lives.
We support clients through all phases of development and commercialization.
Our Patients Define Us
The name “Andelyn” was chosen to pay tribute to two brave young patients that participated in pivotal clinical trials that make today’s gene therapies possible.
Updates from Andelyn
Media Release
August 25, 2021
TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers.
August 23, 2021
Abstract: Andelyn Biosciences, a full-spectrum gene therapy CDMO organization that supports clients from preclinical studies through phase III trials, originally...
June 20, 2021
Adeno-associated viruses (AAV) are small viruses that can infect humans and other primate species. The particularity about AAV is that...
Media Release
March 18, 2021
COLUMBUS, Ohio – Andelyn Biosciences, Inc, a contract development and manufacturing organization (CDMO) and an affiliate company of Nationwide Children’s Hospital, has...
Our Employees Fuel Our Success
Andelyn is made up of an Inspired, Innovative and Compassionate team that contribute towards a rich company culture. We are always looking for great people who want to do great things.